The chart below summarises average weight loss reported in the major clinical studies for oral semaglutide tablets and Wegovy injections
Heart Failure , 11 (2), e004519
While cost, accessibility, and long-term safety considerations persist, current evidence supports its role as a cornerstone
It responds to signals from the body and adjusts temperature by triggering sweating, shivering, and other responses
Clinical Results: Studies show that most participants lose up to 15-20% of their body weight with semaglutide treatment
Unlike one-size-fits-all treatment, PlexusDx adapts therapy based on your response and genetic predispositions, maximizing both sleep apnea improvement and sustainable weight loss